NERV Q4 2024 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$58M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$5M

Net Income

-$4M

EPS (Diluted)

$-0.56

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$249,650

Balance Sheet

Total Assets

$37M

Total Liabilities

$63M

Stockholders' Equity

-$26M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$5M	-$7M	+36.9%
Net Income	-$4M	-$9M	+52.7%